Endo International plc
ENDPDelisted Sep 14, 2022- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001593034
Endo International plc was delisted on Sep 14, 2022; its insiders filed their last Form 4 on Aug 17, 2022; 152 institutions reported holding it in 13F filings for Q2 2022, worth $65.0M in total; no superinvestor held it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Endo International plc insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Endo International plc, current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Tursi James Patrick | Executive VP, Global R&D | 0 | Aug 17, 2022 | 0 |
| Maletta Matthew Joseph | EVP, CLO & Company Secretary | 351,085 | Mar 31, 2022 | 0 |
| Coleman Blaise | President, CEO | 422,066 | Mar 31, 2022 | 0 |
| Barry Patrick A | EVP & Pres,Global Comm Ops | 169,711 | Mar 31, 2022 | 0 |
| Bradley Mark T. | EVP, Chief Financial Officer | 101,477 | Mar 31, 2022 | 0 |
| Raciti Frank B. | VP, Controller and CAO | 8,821 | Mar 31, 2022 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
No insider trades match these filters.